SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-13-000819
Filing Date
2013-04-15
Accepted
2013-04-15 09:17:44
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 biostar10k123112.htm 10-K 1817023
2 ex10-7.htm EX-10.7 31752
3 ex23-1.htm EX-23.1 4058
4 ex23-2.htm EX-23.2 4083
5 ex31-1.htm EX-31.1 16031
6 ex31-2.htm EX-31.2 15575
7 ex32-1.htm EX-32.1 6711
8 ex32-2.htm EX-32.2 6671
15 graph2011.jpg GRAPHIC 38482
  Complete submission text file 0001185185-13-000819.txt   8896892

Data Files

Seq Description Document Type Size
9 bspm-20121231.xml EX-101.INS 1484466
10 bspm-20121231.xsd EX-101.SCH 66433
11 bspm-20121231_cal.xml EX-101.CAL 45711
12 bspm-20121231_def.xml EX-101.DEF 334300
13 bspm-20121231_lab.xml EX-101.LAB 444088
14 bspm-20121231_pre.xml EX-101.PRE 341613
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34708 | Film No.: 13760059
SIC: 2834 Pharmaceutical Preparations